蚓激酶肠溶胶囊耐酸力测定方法研究

目的：建立并验证蚓激酶肠溶胶囊耐酸力测定方法。方法：采用效价测定法，探索蚓激酶肠溶胶囊耐酸力测定方法的供试品溶液制备条件（微丸溶剂、超声时间、静置时间），并通过分析方法学验证耐酸力测定方法的可行性。结果：微丸溶剂选择磷酸盐缓冲液（pH 6.8）为宜，微丸溶解超声时间为3 min，微丸溶解液的静置时间为10 min；耐酸力测定方法的加样回收率为99.16%；精密度RSD为1.13%；重现性RSD为1.02%；空白微丸和肠溶包衣材料的加入对耐酸力测定无明显影响；微丸溶解液在室温下存放24 h内测定耐酸力无明显影响。结论：蚓激酶肠溶胶囊耐酸力方法的准确度、精密度、重现性、专属性和耐用性均良好，方法学研究符合规定。耐酸力测定方法可用于对蚓激酶肠溶胶囊的耐酸性能检控。

Objective: To establish and validate the method for the determination of acidresistivity of lumbrokinase enteric-coated capsules.Methods: The preparation conditions of the test solution for lumbrokinase entericcoated capsules for acidresistivity test were explored in the term of pellets solvent,ultrasonic time,and static time,by the titer determination method.In addition,the feasibility of acidresistivity testing method was confirmed by the analytical methods.Results: Micro pill solvent selection of phosphate buffer solution(pH 6.8) was appropriate,micro pill ultrasonic dissolving time was 3 min,micro pill solution standing time was 10 min; acid method for the determination of recovery rate was 99.16%;RSD was 1.13%;the reproduced RSD was 1.02%; blank micro pill and enteric coating material added exhibited no significant effect on resistance to acid content; there was no significant effect of micro pill solution at room temperature stored within 24 hours on the determination of resistance to acid.Conclusion: The results demonstrate the accuracy,precision,repeatability,specificity and durability of the acidresistivity test,which coincides with provisions of analytical methods.Furthermore,the acidresistivity tests proved to be efficient for determination of acidresistivity of lumbrokinase enteric-coated capsules.

[1] 周海,王春维,张怡,等.蚓激酶的提取纯化及性质研究.中国生化药物杂志,2011,32(3):212 ZHOUH,WANGCW,ZHANGY,et al.Purification and characterization of lumbrokinas[J].Chin J Biochem Pharm,2011, 32(3):212
[2] 中国药典2015年版.二部[S].2015:1413 ChP 2015.Vol Ⅱ[S].2015:1413
[3] 刘向荣,胡建新.国产与进口奥美拉唑肠溶制剂的质量对比[J]. 中国药师,2005,11(10):1196 LIU XR,HU JX.Quality comparison between domestic and imported omeprazole enieric-coated preparation[J].China Pharm,2005,11(10):1196
[4] 王景田,李晔.奥美拉唑胶囊的含量及体外溶出度比较[J].中国药学杂志,1999,34(6):409 WANG JT,LI H.Comparison on content and dissolution of losec with omeprazole capsule[J].Chin Pharm J,1999,34(6):409
[5] WS1-(X-120)-2003Z泮托拉唑钠肠溶片[S].2003:167 WS1-(X-120)-2003Z Pantuolazuona Changrangpian[S].2003:167
[6] 徐慧娟,傅美景,雷锦璟.HPLC法测定泮托拉唑钠肠溶胶囊的耐酸力[J].黑龙江医药,2010,23(6):881 XU HJ,FU MJ,LEI JJ.Determination of acid-resisting from pantoprazole sodium enteric coated capsule by HPLC[J]. Heilongjiang Med J,2010,23(6):881
[7] 孙宁云,常靓.柳氮磺吡啶肠溶片耐酸力和溶出度检测方法的建立与研究[J].中国现代药物应用,2015,9(17):273 SUN NY,CHANG L.Establishment and research of detection methods for acid tolerance and dissolution rate in sulfasalazine enteric-coated tablet[J].Chin J Mod Drug Appl,2015,9(17):273
[8] 张文静,李明丽,樊永庆,等.埃索美拉唑镁肠溶微丸的制备[J]. 药学与临床研究,2014,22(1):39 ZHANG WH,LI ML,FANG YQ,et al.Preparation of esomeprazole magnesium enteric-coated pellets[J].Pharm Clin Res,2014,22(1):39
[9] 吴云珍,宋旭莹,陆纪宏.甘草酸二铵肠溶胶囊的制备与质量控制[J].医药导报,2011,30(11):1507 WU YZ,SONG XY,LU JH.Preparation and quality control of diammonium glycyrrhizinate enteric-coated capsules system[J].Her Med,2011,30(11):1507
[10] 张霞,任萃文.雷贝拉唑钠肠溶微丸的处方工艺研究[J].中国当代医药,2011,18(24):46 ZHANG X,REN CW.Preparation technology research of rabeprazole sodium enteric-coated pellets[J].China Mod Med, 2011,18(24):46
[11] 中国药典2015版.四部[S].2015:121 ChP 2015.Vol Ⅳ[S].2015:121
[12] 国家食品药品监督管理局标准.YBH10392005蚓激酶肠溶胶囊(60万单位)[S].2005 The CFDA Standards.YBH10392005 Yinjimei Changrong Jiaonang Lumbrokinase Enteric-coated Capsules(60 million units)[S]. 2005